3652 results for «231»
3652 results
Featured cases - Non-transfemoral TAVI access
26 Nov 2024 – From PCR London Valves 2024
Delve into this session showcasing a range of non-transfemoral TAVI access techniques from PCR London Valves 2024. Discover alternative approaches such as transiliac, transsubclavian, and transcaval access, employed to overcome complex anatomical challenges. Learn how to navigate tortuous vasculature, snare-assisted TAVR, and transform access when traditional...
Featured cases - TAVI nightmares (Part 3)
26 Nov 2024 – From PCR London Valves 2024
Brace yourself for a deep dive into TAVI nightmares from PCR London Valves 2024. Uncover cases involving severe complications such as annular ruptures, transvalvular regurgitation, instrument failures, and post-dilation balloon ruptures. Witness how skilled clinicians navigated these high-stakes scenarios and implemented life-saving interventions. Gain invaluable insights...
Featured Research - Aortic valve (Part 8)
25 Nov 2024 – From PCR London Valves 2024
Delve into the cutting-edge research presented at PCR London Valves 2024 in this comprehensive session. Discover the latest advancements in aortic valve interventions, including AI-based predictive modeling for TAVR valve selection, insights into TAVR outcomes for bicuspid aortic valve with small annulus, the impact of prosthesis-patient...
Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence
26 Nov 2024 – From PCR London Valves 2024
Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!
You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and...
Transcatheter tricuspid valve replacement - The fundamentals
26 Nov 2024 – From PCR London Valves 2024
Interested in learning the key steps for successful transcatheter tricuspid valve replacement?
Join this session to refine your skills in patient selection, procedural planning and execution. You'll explore a real-world case of a 62-year-old patient with heart failure symptoms and gain insights from the TRISCEND II study.
Featured research - Aortic valve (Part 10)
26 Nov 2024 – From PCR London Valves 2024
Explore the latest research and insights in the field of aortic valve interventions through this featured research session. Discover cutting-edge studies on topics ranging from one-year outcomes after TAVI in different valve types to the impact of frailty and mobility on post-TAVI outcomes, and much more....
Featured research - Valves and beyond
26 Nov 2024 – From PCR London Valves 2024
This session features a selection of the latest research and insights from PCR London Valves 2024, covering a wide range of topics in valvular and structural heart interventions. Discover the early results of a new TTVR system, compare the performance of different TAVI devices, explore long-term...
Featured cases - When the cardiologist meets the surgeon
26 Nov 2024 – From PCR London Valves 2024
Dive into a collection of captivating clinical cases where the cardiologist and surgeon collaborate to tackle complex cardiovascular challenges. From direct vision TAVI implantation during left ventricular assist device surgery to managing iatrogenic annulus rupture during TAVR, this session offers invaluable insights into the art of...
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
